Ontx stock prediction

image

Stock Price Forecast

The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +714.81% increase from the last price of 1.35.

Full
Answer

How often are the ontx stock predictions updated?

“ONTX” stock predictions are updated every 5 minutes with latest exchange prices by smart technical market analysis. Q&A about “ONTX” projections. At Walletinvestor.com we predict future values with technical analysis for wide selection of stocks like Onconova Therapeutics Inc.

Is ontx a good investment for making money?

Currently there seems to be a trend where stocks in the Healthcare Manufacturing sector (s) have been popular in this period. Our Ai stock analyst implies that there will be a negative trend in the future and the ONTX shares are not a good investment for making money.

What does ontx stand for?

Onconova Therapeutics (ONTX) stock price prediction is 6.985950159618 USD. The Onconova Therapeutics stock forecast is 6.985950159618 USD for 2023 February 15, Wednesday; and 40.054 USD for 2027 February 15, Monday.

Do analysts agree Onconova Therapeutics (ontx) stock’s price targets?

3 Wall Street analysts have issued ratings and price targets for Onconova Therapeutics in the last 12 months. Their average twelve-month price target is $15.00, suggesting that the stock has a possible upside of 9,900.00%. The high price target for ONTX is $25.00 and the low price target for ONTX is $8.00.

image


Is ONTX stock a good buy?

Onconova Therapeutics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.


Should I buy ORTX stock?

Out of 4 analysts, 1 (25%) are recommending ORTX as a Strong Buy, 1 (25%) are recommending ORTX as a Buy, 1 (25%) are recommending ORTX as a Hold, 0 (0%) are recommending ORTX as a Sell, and 1 (25%) are recommending ORTX as a Strong Sell. What is ORTX’s earnings growth forecast for 2022-2024?


Why did ONTX stock drop so much?

Onconova Therapeutics’ stock price plummeted by more than 70% Monday morning after the company announced disappointing results from late-stage testing of its lead new drug candidate.


Will ONTX reverse split?

Onconova Therapeutics, Inc. (ONTX) will effect a one-for-fifteen (1-15) reverse split of its common stock. The reverse stock split will become effective on Friday, May 21, 2021.


Is Orchard Therapeutics a good investment?

Orchard Therapeutics has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 3 buy ratings, 2 hold ratings, and 1 sell rating.


Will ONTX rise?

Onconova Therapeutics Inc (NASDAQ:ONTX) The 3 analysts offering 12-month price forecasts for Onconova Therapeutics Inc have a median target of 11.00, with a high estimate of 12.00 and a low estimate of 7.00. The median estimate represents a +739.69% increase from the last price of 1.31.


What is a 1 for 15 reverse stock split?

In a 1-for-15 reverse stock split, each 100 shares previously purchased is now 7 shares. This split will require some changes to how you continue the Snider Investment Method® in this position.


What does onconova therapeutics do?

Onconova Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel products to treat for patients with cancer. The Company has proprietary targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation.


What is reverse split on a stock?

When a company completes a reverse stock split, each outstanding share of the company is converted into a fraction of a share. For example, if a company declares a one for ten reverse stock split, every ten shares that you own will be converted into a single share.


Should I buy or sell Onconova Therapeutics stock right now?

3 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for Onconova Therapeutics in the last twelve months. There a…


What is Onconova Therapeutics’ stock price forecast for 2022?

3 brokerages have issued 1 year price targets for Onconova Therapeutics’ stock. Their forecasts range from $7.00 to $12.00. On average, they antici…


How has Onconova Therapeutics’ stock price performed in 2022?

Onconova Therapeutics’ stock was trading at $2.55 on January 1st, 2022. Since then, ONTX shares have decreased by 47.8% and is now trading at $1.33…


Are investors shorting Onconova Therapeutics?

Onconova Therapeutics saw a decrease in short interest in the month of May. As of May 31st, there was short interest totaling 65,800 shares, a decr…


When is Onconova Therapeutics’ next earnings date?

Onconova Therapeutics is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022. View our earnings forecast f…


How were Onconova Therapeutics’ earnings last quarter?

Onconova Therapeutics, Inc. (NASDAQ:ONTX) released its quarterly earnings data on Wednesday, May, 11th. The biopharmaceutical company reported ($0….


When did Onconova Therapeutics’ stock split? How did Onconova Therapeutics’ stock split work?

Onconova Therapeutics’s stock reverse split on Friday, May 21st 2021. The 1-15 reverse split was announced on Thursday, May 20th 2021. The number o…


Who are Onconova Therapeutics’ key executives?

Onconova Therapeutics’ management team includes the following people: Dr. Steven M. Fruchtman M.D. , CEO, Pres & Director (Age 71, Pay $903.45k)…


Who are some of Onconova Therapeutics’ key competitors?

Some companies that are related to Onconova Therapeutics include Greenwich LifeSciences (GLSI) , Evelo Biosciences (EVLO) , Epizyme (EPZM) , Da…


What is Onconova Therapeutics’s consensus rating and price target?

According to the issued ratings of 3 analysts in the last year, the consensus rating for Onconova Therapeutics stock is Buy based on the current 3…


Do Wall Street analysts like Onconova Therapeutics more than its competitors?

Analysts like Onconova Therapeutics stock more than the stock of other Medical companies. The consensus rating score for Onconova Therapeutics is 3…


Do MarketBeat users like Onconova Therapeutics more than its competitors?

MarketBeat users like Onconova Therapeutics stock more than the stock of other Medical companies. 68.91% of MarketBeat users gave Onconova Therapeu…


Does Onconova Therapeutics’s stock price have much upside?

According to analysts, Onconova Therapeutics’s stock has a predicted upside of 355.93% based on their 12-month price targets.


What analysts cover Onconova Therapeutics?

Onconova Therapeutics has been rated by Noble Financial in the past 90 days.


How much is Onconova Therapeutics stock worth in 2021?

The Onconova Therapeutics stock price gained 2.14% on the last trading day (Friday, 9th Jul 2021), rising from $6.07 to $6.20. , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.33% from a day low at $6.00 to a day high of $6.26. The price has fallen in 7 of the last 10 days and is down by -16.55% for this period. Volume fell on the last day by -90 thousand shares and in total, 234 thousand shares were bought and sold for approximately $1.45 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.


Does Onconova Therapeutics gain volume?

Onconova Therapeutics gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical “sell-offs”.


Onconova Therapeutics Inc ( ONTX ) Stock Market info

Recommendations: Buy or sell Onconova Therapeutics stock? Wall Street Stock Market & Finance report, prediction for the future: You’ll find the Onconova Therapeutics share forecasts, stock quote and buy / sell signals below.


Also on walletinvestor.com

Term Box: Best Onconova Therapeutics Inc forecast, ONTX stock price prediction, ONTX forecast, Onconova Therapeutics Inc finance tips, ONTX prediction, Onconova Therapeutics Inc analyst report, ONTX stock price predictions 2022, Onconova Therapeutics Inc stock forecast, ONTX forecast tomorrow, Onconova Therapeutics Inc technical analysis, ONTX stock future price, Onconova Therapeutics Inc projections, Onconova Therapeutics Inc market prognosis, ONTX expected stock price..


Onconova Therapeutics (NASDAQ:ONTX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst’s rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy).


Analyst Price Target Consensus

Sign-up to receive the latest news and ratings for ONTX and its competitors with MarketBeat’s FREE daily newsletter.


Analyst Ratings By Month

The chart below shows how a company’s ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.


Average Share Price and Price Target by Month

The chart below shows how a company’s share price and consensus price target have changed over time. The dark blue line represents the company’s actual price. The lighter blue line represents the stock’s consensus price target.


Onconova Therapeutics (NASDAQ:ONTX) Analyst Ratings Frequently Asked Questions

According to the issued ratings of 2 analysts in the last year, the consensus rating for Onconova Therapeutics stock is Buy based on the current 2 buy ratings for ONTX. The average twelve-month price target for Onconova Therapeutics is $11.50 with a high price target of $12.00 and a low price target of $11.00.


ONTX earnings per share forecast

What is ONTX ‘s earnings per share in the next 3 years based on estimates from 1 analyst?


ONTX revenue forecast

What is ONTX ‘s revenue in the next 2 years based on estimates from 1 analyst?


ONTX revenue growth forecast

How is ONTX forecast to perform vs Biotechnology companies and vs the US market?

image

Leave a Comment